Valentina Reiner

Nest AS is an online store based in Oslo, Norway that was founded in 2018. The Norwegian company offers a wide range of trendy fashion, interior, and accessories for women. Nest AS takes pride in providing well-known quality brands such as Part Two, Ella & Iil, Reunion, and Is of Norway, among others. The company's online store is one of the largest in Norway, and customers can shop for their favorite items with ease.

Turtle Capital Investment Ltd. provides investment services.

Part of Philip Morris International, Inc., Vectura Group Services Ltd. provides business support services. The company is based in London, UK.

Lindt & Sprungli (USA), Inc. manufactures candy and other confectionery products. It offers truffles, boxed chocolates, bars, and European specialties, milk chocolates, dark and white chocolates, and blends. The company was founded in 1925 and is headquartered in Stratham, NH.

iJet Technologies, Inc. engages in the integrates aircraft operational data, IP communication links and airline ground systems into software solutions. Its data access platform acquires, transforms and makes aircraft data available to applications and analytics, in the air and on the ground. The firm’s solutions begins with the iJet data access platform which includes a data platform onboard each aircraft connected via IP links to an intelligent ground platform. The company was founded by Jan Petter Roed and is headquartered in Seattle, WA.

Part of Future Plc, Hotel de la Paix is a 4-star hotel located in Lausanne, Switzerland. The hotel offers charming suites and rooms with views of Lake Geneva, as well as restaurants and bars. Additionally, the hotel provides seminar and reception spaces for conferences and events.

Twin Dolphins Holding AG engages in the acquisition, holding, management, and sale of participations in companies. It also acquires, administers, and sells real estate properties. The company was founded on April 26, 2013 and is headquartered in Baar, Switzerland.

Onelife SA provides investment advice. The private company is based in Lugano, Switzerland. and has subsidiaries in Luxembourg, Switzerland and Liechtenstein. The Swiss company was founded in 2006 by Enrico Braglia. Enrico Braglia has been the CEO since 2006.

SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland.

Onelife SA (Private Equity) (Onelife) is a private equity firm founded in 2006 by Enrico Braglia. The firm is headquartered in Switzerland.

HeiQ Materials AG develops and manufactures antimicrobial silver and other sustainable textile effects. It offers textile brands innovation research and development, customized chemical manufacturing, and ingredient branding in one. The company was founded by Carlo Centonze and Murray Height in 2005 and is headquartered in Schlieren, Switzerland.

Part of Pierrel SpA, Farma Resa Imp SRL is an Italian company that specializes in the preparation of pharmaceutical tests. The company is based in Cantu, Italy. Farma Resa Imp was acquired by Pierrel Research Italy SpA on September 30, 2010 for $2.14 million.

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

Artsana SpA manufactures and distributes cosmetics, health and beauty products. It specializes in wide range of baby-care products, mono-brand and multi-brand baby retail, as well as a wider range including cosmetics, supplements, condoms and sex products. The company was founded by Pietro Catelli in 1946 and is headquartered in Grandate, Italy.

Part of The National Geographic Society, Inc., National Geographic Holdings, Inc. is a nonprofit scientific and educational organization. The company is based in Washington.

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

InSphero AG supplies organotypic 3D microtissues for efficiency testing and toxicology in drug development. It offers 3D insight Islet, 3D InSight Tumor, Gravity TRAP ULA Plates, Cytotoxicity Assay Kit, 3D InSight in Vitro Toxixology services, imaging and automation. he company was founded by Jan Lichtenberg, Jens M. Kelm, Simon P. Hoerstrup and Wolfgang Moritz on March 26, 2009 and is headquartered in Schlieren, Switzerland.

Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA.

Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany.

HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.

Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier.